Transforming growth factor β and bone morphogenetic protein actions in brain tumors

Laia Caja1, Claudia Bellomo1, Aristidis Moustakas1

  • 1Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala University, Box 582, SE-751 23 Uppsala, Sweden; Ludwig Cancer Research, Science for Life Laboratory, Uppsala University, Box 595, SE-751 24 Uppsala, Sweden.

FEBS Letters
|May 11, 2015
PubMed

Insights

Transforming growth factor-β (TGF-β) and bone morphogenetic protein (BMP) signaling pathways have opposing roles in brain cancers. TGF-β promotes malignancy, while BMPs suppress it by inducing tumor cell differentiation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Neuroscience

Background:

  • Transforming growth factor-β (TGF-β) family members are involved in various cancers.
  • The TGF-β and bone morphogenetic protein (BMP) signaling pathways have context-dependent roles in tumorigenesis, acting as either tumor suppressors or promoters.
  • In brain malignancies, TGF-β signaling is linked to oncogenic development and progression.

Purpose of the Study:

  • To examine the roles of TGF-β and BMP signaling in brain malignancies.
  • To understand how these pathways influence tumor progression and heterogeneity.
  • To identify potential therapeutic targets for brain tumors.

Main Methods:

  • Review of existing literature on TGF-β and BMP signaling in brain tumors.
  • Analysis of the context-dependent actions of these pathways.
  • Discussion of the impact on cancer stem cells and tumor cell differentiation.

Main Results:

  • TGF-β signaling promotes oncogenic development and progression in brain malignancies.
  • BMP signaling acts as a tumor suppressor by inducing differentiation, particularly evident in glioblastoma.
  • Mechanisms linking tumor cell differentiation to invasion are explored.

Conclusions:

  • TGF-β and BMP signaling pathways play critical, opposing roles in brain tumor biology.
  • Understanding these pathways' actions on cancer stem cells is key to explaining tumor progression.
  • Targeting TGF-β and BMP signaling offers potential for novel therapeutic strategies in brain cancer treatment.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
89.4K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.4K